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Predicting 1-year mortality after elective
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Jens Eldrup-Jorgensen, MD,c and Jack L. Cronenwett, MD,a for the Vascular Study Group of Northern
New England, Lebanon, NH; and Portland, Me
Objective: Benefit of prophylactic abdominal aortic aneurysm (AAA) repair requires sufficient survival to overcome
operative risk. Since death within 1 year of elective open or endovascular (EVAR) infrarenal AAA repair likely indicates
ineffective treatment, we developed a prediction model for 1-year mortality to aid clinical decision-making.
Methods:We used a prospective registry of 1387 consecutive patients who had undergone elective AAA repair from 2003
to 2007 by 50 surgeons from 11 hospitals in Northern New England. Cox proportional hazards were used to analyze
potential risk factors for 1-year mortality, including medical comorbidities, aortic clamp site, preoperative risk factor
modification (eg, beta-blockade), and aneurysm diameter.
Results: Thirty-day and 1-year mortality after open repair (n  748) was 2.3% and 5.8%, and after EVAR (n  639) was
0.5% and 5.7%, respectively. Factors associated with death within 1-year after open repair were: age > 70 (P  .007;
hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.3-6.3), history of chronic obstructive pulmonary disease (COPD)
(P< .0001; HR 3.6, 95% CI 1.9-7.0), chronic renal insufficiency (creatinine> 1.8) (P .008; HR 2.8, 95% CI 1.3-6.2)
and suprarenal aortic clamp site (P< .0001; HR 3.8, 95% CI 1.9-7.5). Depending on the number of risk factors present,
predicted 1-year mortality after open repair varied from 1% in patients with no risk factors to 67% in patients with four
risk factors. Our model demonstrated excellent correlation between observed and expected deaths (r 0.97). For EVAR,
identified risk factors for death within 1 year included a history of congestive heart failure (CHF) (P .002; HR 3.2, 95%
CI 1.6-6.5), and aneurysm diameter>6.5 cm (P .04 95%CI 1.0-4.8). Depending on the number of risk factors present,
predicted mortality ranged from 3.6% to 23%. A model using CHF and aneurysm diameter correlated well with actual
mortality rates, with an observed to expected ratio of 0.96.
Conclusion: Predictors of 1-year mortality can identify patients less likely to benefit from elective AAA repair. These
factors differ for open repair vs EVAR and should be considered in individual patient decision-making. Our EVARmodel
had less impact on 1-year survival, even if CHF and large AAA diameter were present. However, a combination of age,
COPD, renal insufficiency, and need for suprarenal clamping have significant impact on 1-year mortality after open AAA
repair. Consideration of these variables should assist decision-making for elective AAA repair, especially in borderline
cases. ( J Vasc Surg 2009;49:838-44.)Elective abdominal aortic aneurysm (AAA) repair is a
prophylactic operation designed to improve survival by
preventing aneurysm rupture. Decision-making requires a
careful analysis of rupture risk vs operative risk, but also of
life expectancy, since patients must live long enough for the
benefit of surgical repair to overcome operative risk. Pre-
diction of survival after AAA repair has historically focused
on the early postoperative (in-hospital or 30-day) or long-
term (5-year) intervals.1-9 In this regard, early survival
demonstrates the safety of AAA repair, but does not convey
late benefit. Similarly, 5-year survival is determined by
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838many other causes of late mortality, principally cardiac
disease, stroke, and malignancy, and is difficult to predict
on an individual basis. Clinical decision-making to recom-
mend AAA repair often focuses on 1- to 2-year life expect-
ancy in discussions with patients, against which the annual
aneurysm rupture risk is compared.
The purpose of this study was to develop a risk predic-
tion model for mortality during the first year after elective
AAA repair. Although the 1-year time threshold is some-
what arbitrary, most would agree that death within 1 year of
elective AAA repair indicates ineffective or unnecessary
treatment. Such a prediction model could help identify
patients who will benefit most from surgery, and potentially
those with a short life expectancy in whom medical man-
agement would be preferred.
METHODS
Subjects and database. We utilized data collected
prospectively by the Vascular Study Group of Northern
New England (VSGNNE), a regional cooperative quality
improvement initiative developed in 2002 to study regional
outcomes in vascular surgery. Further details on this regis-
try have been published previously.10 Of note, registry data
are compared with hospital claims data in regular audits to
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surgeons.
We included only patients who underwent elective
open or endovascular AAA repair of infrarenal aneurysms.
Patients with ruptured or symptomatic aneurysms were
excluded from this analysis, as were aneurysms that re-
quired renal or visceral artery reconstruction. However,
pararenal AAAs that required aortic clamping above one or
both renal arteries, but with an infrarenal anastomosis, were
included.
Definitions. Patients were evaluated for pre-existing
medical comorbidities including chronic obstructive pul-
monary disease (COPD; chart history), congestive heart
failure (CHF; chart history or documented ejection frac-
tion50% on preoperative testing), coronary artery disease
(CAD; any history of angina, myocardial infarction [MI],
prior coronary intervention, or EKG changes consistent
with previous MI), chronic renal insufficiency (CRI;
Cr 1.8 mg/dL), end-stage renal disease (ESRD; on dial-
ysis), diabetes mellitus (DM; chart history, designated as
diet-controlled, on oral hypoglycemic agents, or on insu-
lin), hypertension (HTN; chart history or blood
pressure140/90), hyperlipidemia (HLIP; chart history),
and prior aortic surgery.
Additionally, patients were evaluated for additional
preoperative factors including a family history of aneurysm,
location of intended aortic clamp site, and perioperative
statin, aspirin, and beta-blocker use. Also, operating sur-
geons for endovascular aneurysm repair (EVAR) patients
were asked to prospectively judge whether patients were
unfit for an open operation.
Data collection. Trained nurses or clinical data ab-
stractors entered data prospectively on over 70 clinical and
demographic variables (www.VSGNNE.org). Research an-
alysts were blinded to patient, surgeon, and hospital iden-
tity. All patients who underwent AAA repair by 50 partici-
pating surgeons in 11 study hospitals from January 1, 2003
to September 30, 2007 were included in the analysis. A
current version of the Social Security Death Index as well as
1-year follow-up data obtained as part of VSGNNE were
used to confirm the survival status of all patients during the
first year after AAA repair.
Risk model construction. The primary outcome
measure was mortality at 1 year and the secondary endpoint
was 30-day mortality. At the time of data analysis, 84% of
open patients and 77% of EVAR patients were at least 1 year
from their operation. Survival was calculated using life table
methodology.
Univariate analysis was performed using a Pearson Cor-
relation Coefficient. Risk factors found by univariate anal-
ysis to be associated with 1-year mortality with a P value of
0.1 were used in the multivariate Cox proportional haz-
ards model. This model was then was used to calculate
hazard ratios (HR) and 95% confidence intervals (CI) for
postoperative death within 1 year of surgery.
Separate models were constructed for open AAA repair
and EVAR patients using factors found in multivariate
analysis to predict 1-year mortality. Using Cox-Snell resid-uals, predicted 1-year mortality was determined based on
each patient’s risk factor profile. The predictive ability of
eachmodel was then evaluated by generating an observed-to-
expected outcome ratio across the range of risk identified.
All analyses were performed using Microsoft Excel
(Redmond, Wash) and STATA (College Station, Tex).
RESULTS
Patient characteristics. A total of 1387 patients un-
derwent elective repair of an asymptomatic infrarenal AAA
by either an open procedure (n  748) or EVAR (n 
639). Patients in the EVAR group tended to be older (74 vs
71 years), had smaller aneurysm diameter (5.7 vs 6.0 cm),
and were more likely to have a history of CHF and smoking
(Table).
Mortality. Thirty-day and 1-year mortality was 2.3%
and 5.8% after open repair, and 0.5% and 5.7% after EVAR,
respectively (Fig 1). Thirty-day mortality was significantly
higher after open AAA repair (P  .001), but 1-year
mortality was comparable with EVAR (P  .91). In the
open cohort, there were 43 patient deaths within 1 year of
operation of which 17 (40%) occurred within 30 days, and
36 deaths within 1 year of EVAR, with only three (8%) of
these within 30 days.
Open AAA repair. Univariate predictors for 1-year





n  639 P value
Mean age (y) 71 74 .001
Male gender 74% 82% .001
Aneurysm diameter (cm) 6.0  1.3 5.7  1.0 .0001
Comorbidities
CHF 6% 13% .0001
CAD 31% 31% .89
H/O coronary intervention 29% 31% .63
COPD 36% 39% .60
CRI (creatinine 1.8) 8% 7% .47
HTN 75% 78% .49
Diabetes mellitus 14% 18% .17
Diet-controlled 4% 5%
Oral meds 8% 11%
On insulin 1% 1%
Suprarenal clamp 14% — —
Deemed “unfit” for open
surgery — 28% —
Risk factor modification
Perioperative -blockade 81% 70% .0001
ASA/Plavix 65% 68% .87
Statin 54% 59% .71
Smoking
Current (w/i 1 y) 39% 30% .0001
Prior (quit 1 y) 47% 57% .37
Never 8% 12% .21
EVAR, Endovascular aneurysm repair;CHF, congestive heart failure;CAD,
coronary artery disease; COPD, chronic obstructive pulmonary disease;
CRI, chronic renal insufficiency; H/O, history of; HTN, hypertension;
ASA, aspirin.(P  .0001), family history of AAA (P  .04), anterior
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site (P  .0001). By multivariate analysis, predictors of
1-year mortality in order of importance included a suprare-
nal aortic clamp site (P .0001; HR 3.8, 95% CI 1.9-7.5),
a history of COPD (P  .0001; HR 3.6, 95% CI 1.9-7.0),
age 70 (P  .007; HR 2.9, 95% CI 1.3-6.3), and CRI
(P  .008; HR 2.3, 95% CI 1.3-6.2).
Predicted 1-year mortality using themultivariatemodel
ranged from 1.2% in patients with no risk factors present to
67% if all risk factors were present (Fig 2). A model using
simply the number of these risk factors present showed
good correlation (r .97) between predicted and actual
mortality, which ranged from 1.2% to 66% in these groups
(Fig 3, A). Actual survival of patients with 0-4 risk factors
stratified well by Kaplan-Meier analysis (Fig 4).
Endovascular AAA repair. By univariate analysis,
age 70 (P  .02), CHF (P  .007), COPD (P  .007),
CRI (P .04), and aneurysm diameter6.5 cm (P .02)
were found to be predictive of 1-year mortality after EVAR.
Also, a designation of unfit for open operation, which was
given to 28% of EVAR patients (n 182), was predictive of
Fig 1. Kaplan-Meier curves demonstrating 1-year survival after
open and endovascular aneurysm repair (EVAR).
Fig 2. Predicted mortality at 1 year after open aneurysm repair
stratified by risk factor combinations.1-year mortality (P  .056).By multivariate analysis, however, only a history of
CHF (P  .002; HR 3.2, 95% CI 1.6-6.5) and aneurysm
size 6.5cm (P  .04; HR 2.2 95% CI 1.0-4.8) were
predictive of 1-year mortality after EVAR. Patients without
CHF and an aneurysm greater than 6.5 cm had a predicted
mortality at 1 year of 3.6%, while those with both risk
factors had a predicted mortality of 23% at 1 year. The
observed-to-expected ratio was excellent for this model at
0.96 (Fig 3, B).
Diameter of AAA at time of repair. Aneurysm diam-
eter at the time of repair was evaluated for each risk group.
As the number of risk factors increases, the diameter at
repair increased significantly. Mean aneurysm diameter for
patients with no independent risk factors for mortality
within 1 year was 5.6 cm. Those patients with three or four
independent risk factors had a mean aneurysm diameter of
6.7 cm, which was statistically larger than the no risk factor
group (P  .0006) (Fig 5).
DISCUSSION
Numerous publications have found medical comor-
bidities that are independent predictors of in-hospital or
30-day mortality after open AAA repair, including CHF,
CRI, COPD, CAD, advanced age, and aneurysm diame-
ter.6,11,12,13-17 Long-term (usually 5 years) mortality risk
assessment models have been developed using similar risk
factors with variable degrees of success.3,4,7 For EVAR,
Barnes and colleagues demonstrated that aneurysm diam-
eter was independently predictive of perioperative mortal-
ity, and this along with CRI, age, and ASA (American
Society of Anesthesiologists) score were predictive of 3-year
and 5-year mortality after EVAR.18 Others have also dem-
onstrated aneurysm diameter, age, and CRI to be indepen-
dent predictors of late death after EVAR.19,20
In our patient population, less than half of the deaths
that occurred within the first year after open operation
occurred within 30 days. For the EVAR group, this number
is even more striking with just 8% of deaths within 1 year
attributable to 30-day mortality. This emphasizes the im-
portance of using longer survival (at least 1 year) to assess
the overall benefit of AAA repair, even though most sur-
geons focus on in-hospital results.
One-year mortality was selected for analysis to provide
a useful counterpoint to the often cited annual AAA rup-
ture risk when discussing decision making with patients.
Further, we reasoned that most patients and surgeons
would judge death within 1 year of AAA repair to represent
ineffective treatment, unless an aneurysm was very large
with very high rupture risk. Finally, convalescence time for
operative recovery, especially for open repair, occupies a
significant proportion of the first year after surgery, making
longer survival even more important. For these reasons, we
developed a model to predict 1-year mortality.
For open AAA repair, our analysis of 1-year mortality
yielded a highly predictive risk assessment model. Age70
years, CRI, COPD, and a suprarenal clamp requirement
were all found to be independent predictors of mortality
and are available preoperatively. Although suprarenal clamp
rysm
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previous reports, 21-25 in our patient population this was an
important predictor of 1-year mortality (and also 30-day
mortality, data not shown). This was especially true when
suprarenal clamp site is combined with other medical co-
morbidities (Fig 2). It is unclear why suprarenal clamp site
correlates with 1-year mortality. In part, this is related to
postoperative mortality, but 53% of patients who had a
suprarenal clamp andwho died within 1 year did so after the
initial 30 days. It is possible that the need for suprarenal
clamping is a surrogate marker for more advanced disease,
or perhaps correlates with other operative complications
such as renal failure, which might lead to higher mortality
rates. Additionally, although suprarenal clamp site is usually
chosen preoperatively based on axial imaging, it is some-
what subject to surgeon’s preference and can also change
intraoperatively due unforeseen technical challenges.
Patients with none of the above risk factors had a 1-year
Fig 3. Predicted and actual 1-year mortality rates based
aortic aneurysm (AAA) repair (A) and endovascular aneu
Fig 4. Kaplan-Meier curve demonstrating 1-year survival after
open aneurysm repair stratified by risk factor groups.mortality of only 1.2% after open repair, while those pa-tients with three or four risk factors had predicted mortality
rates ranging from 22% to 67% at 1 year. This would
suggest that patients with few of these risk factors are good
candidates for surgery at smaller aneurysm diameters. In
contrast, patients with several of these risk factors have a
substantially higher 1-year mortality after open operation,
suggesting that repair should only be performed at larger
AAA diameter, unless EVAR can be performed.
Although rupture risk based on aneurysm diameter is
somewhat imprecise, an accepted estimate for rupture risk
in patients with 5 to 5.9 cm aneurysms in the absence of
rapid expansion is6.5% per year.26 Current general prac-
tice is to repair aneurysms 5.5 cm. In a high-risk patient
with three or four risk factors, the high risk of mortality
within 1 year of elective open AAA repair substantially
exceeds the rupture risk of most 5.5 cm AAAs. Interest-
ingly, when patients undergoing open repair were stratified
by aneurysm diameter at repair, it appears that surgeons are
taking these risk factors into account since patients with
e number of risk factors identified after open abdominal
repair (EVAR) (B).
Fig 5. AAA diameter at time of repair (and estimated annual
rupture risk) (gray bars) compared with predicted 1-year mortality
after open abdominal aortic aneurysm (AAA) repair (black bars) as
a function of number of risk factors present for mortality after open
repair, and rupture risk as a function of diameter estimated by the
authors based on relevant literature.30-33on thhigher risk for 1 year mortality had larger diameters at time
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(Fig 5, gray bars) is compared with predicted 1-year mor-
tality for each risk factor group (Fig 5, black bars), it appears
that patients with multiple risk factors perhaps should have
much larger aneurysms before open repair in order to
justify the risk of operation. In contrast, patients with none
to two risk factors appear to have a favorable ratio of higher
estimated rupture risk compared with lower estimated
1-year mortality (Fig 5). These risk prediction models have
not yet been validated against a separate database, but will
of course be more valuable once this is done. In addition, it
is possible that future analyses of more patients will disclose
other significant predictors of outcome. Finally, decision
making for patients must always be individualized, using
prediction factors to inform, but not to make decisions.
In contrast to open repair, perioperative mortality after
EVAR is rare, even in relatively high-risk patients,9,27-29
but large series have demonstrated short- and long-term
predictors of survival.1,18,19 In our analysis, the 30-day
mortality rate for EVAR patients was only 0.5%. By 1 year,
however, mortality after EVAR reached 5.7%, which was
equivalent to that for open repair. A number of risk factors
were found to be predictive of 1-year mortality in univariate
analysis, including CHF, COPD, age, and aneurysm diam-
eter6.5 cm .However, only CHF and aneurysm diameter
6.5 cm were independent predictors of 1-year mortality
by multivariate analysis. CHF as a single predictor for
mortality after EVAR had a greater impact on survival than
any single risk factor for mortality after open AAA repair
based on the hazard ratios. The other independent predic-
tor, aneurysm diameter6.5 cm also increases rupture risk,
making this variable less helpful in decision making, since it
argues both for and against repair. Creation of a more
comprehensive prediction model for EVAR was not possi-
ble in our study, likely due to a small number of patients
who died within 1 year and interaction between the risk
factors that we identified in the univariate analysis.
Currently, AAA repair is recommended when the an-
eurysm rupture risk exceeds the operative risk. These data
demonstrate that certain patients are at high risk for aneu-
rysm repair, especially by open surgical methods. Embrac-
ing the concept of 1-year survival as a measure of treatment
success can facilitate clinical decision-making before AAA
repair.
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Dr Peter Gloviczki (Rochester, Minn). I enjoyed your paper
very much and would like to congratulate you on an in-depth
analysis of data of mortality at 1 year. You mentioned that you
included 49 surgeons of 11 centers, and what I wanted to hear is if
your data depended on surgeon’s expertise. What has happened is
that more recently we do less open repairs in more complex
patients. We do more suprarenal or supraceliac clamping because
most of the usual bread-and-butter infrarenal aneurysms are re-
paired endovascularly. So I am wondering if surgeon’s experience
is important or not in the outcome.
When we looked recently at results of 126 juxtarenal aneu-
rysms, we found that the level of aortic clamp replacement (supra-
visceral vs suprarenal: supravisceral vs inter-renal) had no signifi-
cant effect on the development of cardiac, pulmonary, or renal
complications nor on mortality. I am wondering if you found a
difference or whether you had enough patients who had suprace-
liac clamping who maybe had a higher mortality.
Otherwise your 1-year outcome data are very similar to ours,
we had a 6% mortality by 1 year after juxtarenal aneurysm repair
and a 0.8% mortality at 30 days, which is very similar to our results
with infrarenal aortic aneurysm.
Dr Adam W. Beck. Although we have the capability of
looking at surgeon effect, we did not do so for this particular study.
I saw your publication regarding juxtarenal aneurysms. We in-
cluded all patients who had an aortic clamp above both renal
arteries, but we did not differentiate suprarenal vs supraceliac. If we
looked at just a clamp above one renal artery, those patients had a
similar outcome to the infrarenal clamp group in our database.
Dr Jack Cronenwett. When we look at these data, we find
some apparent impact of surgeon volume, but the numbers be-
come very small and impossible to accurately analyze yet in multi-
variate analysis. We are using the registry primarily for quality
improvement efforts. But overall, the 30-day mortality results in
both the open and endovascular groups were quite excellent.
Dr Tara Mastracci (Cleveland, Ohio). Thank you for your
very thoughtful analysis. This is an area of interest for us at the
Cleveland Clinic as well. I was wondering about your choice of a
1-year endpoint. In an era where we are now achieving very
acceptable perioperative outcomes for endovascular repair even in
high-risk patients who have multiple comorbidities threateninginstead of 1-year mortality, to better inform the decision to operate
on only the high-risk patients in whom we can actually prolong
survival?
Dr Beck. This is an important point. If you look at most
published risk prediction models for AAA surgery, they look pri-
marily at perioperative mortality. There are also a number of
publications that have identified independent risk factors for mor-
tality at 3 and 5 years, but no risk predictionmodels. Further, many
other factors such as subsequent cancer or heart disease affect
5-year mortality. We chose the 1-year time point because it corre-
sponds well with 1-year rupture risk, which is often discussed with
patients during decision making.
Dr JohnHallett (Charleston, SC). This is really an important
study because the methodology that you are using for vascular has
been used to improve cardiac care in your region of the country.
And, I am interested in how you are going to use this information
now with the surgeons to improve care. Are you going to use this
methodology in a prospective way so the surgeon can advise the
patient? Are you going to use it to advise the surgeon in decision-
making? How are you going to use these data in quality improve-
ment that has been used so well for cardiac surgery?
Dr Beck.We presented these data at the recent meeting of the
Vascular Study Group and it was believed to be important for
future clinical decision making. To facilitate this, it was decided to
make small pocket cards so VSGNNE members could easily re-
member these risk factors.
Dr Maciej Dryjski (Buffalo, NY). What is striking for me is
that congestive heart failure (CHF) is a predictive factor for mor-
tality in the endovascular group but not in the open group. It
seems to me that we perhaps do something different when we treat
endovascularly a patient with an aneurysm. The question is if the
dye given in perioperative evaluation, during the operation, and
then on the follow-up CTs, has an influence on 1-year postopera-
tive mortality?
Dr Beck.We did look at the amount of contrast that patients
received during EVAR in this study. We were trying to look at
preoperative data so that it could help the surgeon and the patient
make decisions before the operation. But in other analyses, we have
not found that contrast volume affected mortality after EVAR.
There were more patients in the EVAR group that had CHF
by percentile, and there were more patients that had more severe
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dent predictor of outcome in the EVAR patients and not in the
open repair patients.
Dr Jerry Goldstone (Cleveland, Ohio). One of the issues that
you did not discuss was gender differences. Were there any differ-
ences male vs female, and in particular, aneurysm size? There has
been some suggestion that women’s aneurysms may rupture at a
smaller size and, therefore, the threshold for operating might be
lower than what we.Dr Beck. We did look at gender. There was no difference in
outcomes between men and women, although your point is well
taken about aneurysm size and rupture risk. Certainly we cannot
prescribe fixed diameter thresholds for elective repair. However,
for patients with three to four identified risk factors for mortality
after open repair, it would appear that repair should be delayed
until a larger diameter is reached. On a patient-by-patient basis,
you definitely would have to consider gender in setting the optimal
diameter threshold for elective repair.
